Veracyte, Inc.VCYTNASDAQ
Loading
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Revenue | 220 | 297 | 361 |
| Gross Profit | 145 | 195 | 248 |
| Operating Income | -82 | -41 | -86 |
| Net Income | -76 | -37 | -74 |
| EBITDA | -60 | -7 | -49 |
| EPS Diluted | -1.11 | -0.51 | -1.02 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Cash & Equivalents | 173 | 154 | 216 |
| Total Current Assets | 243 | 249 | 286 |
| Total Assets | 1,188 | 1,156 | 1,115 |
| Total Current Liabilities | 64 | 63 | 61 |
| Total Liabilities | 91 | 81 | 71 |
| Total Equity | 1,097 | 1,075 | 1,044 |
| Total Debt | 19 | 15 | 13 |
| Net Debt | -154 | -140 | -204 |
| Metric | Dec 21 | Dec 22 | Dec 23 |
|---|---|---|---|
| Operating Cash Flow | -32 | 8 | 44 |
| Capital Expenditure | -5 | -9 | -10 |
| Free Cash Flow | -37 | -1 | 34 |
| Stock-Based Comp | 23 | 27 | 33 |
| Net Change in Cash | -176 | -19 | 62 |